Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability

Author:

Grillot Anne-Laure1,Tiran Arnaud Le1,Shannon Dean1,Krueger Elaine1,Liao Yusheng1,O’Dowd Hardwin1,Tang Qing1,Ronkin Steve1,Wang Tiansheng1,Waal Nathan1,Li Pan1,Lauffer David1,Sizensky Emmanuelle1,Tanoury Jerry1,Perola Emanuele1,Grossman Trudy H.1,Doyle Tim1,Hanzelka Brian1,Jones Steven1,Dixit Vaishali1,Ewing Nigel1,Liao Shengkai1,Boucher Brian1,Jacobs Marc1,Bennani Youssef1,Charifson Paul S.1

Affiliation:

1. Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts 02210, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference31 articles.

1. Antibacterial Resistance Threats in the United States;Centers for Disease Control and Prevention:Atlanta, GA, 2013; http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.

2. Has the era of untreatable infections arrived?

3. The growing burden of antimicrobial resistance

4. 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

5. Antibiotics in the clinical pipeline in 2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3